How has been the historical performance of Brooks Lab.?

Answer:The historical performance of Brooks Lab shows a fluctuating trend in key financial metrics over the past five years.

Breakdown:
Brooks Lab's net sales increased from 63.20 Cr in March 2023 to 82.56 Cr in March 2025, indicating a recovery from a dip in March 2022 when sales were at 91.08 Cr. The total operating income followed a similar pattern, rising to 82.56 Cr in March 2025 from a low of 63.20 Cr in March 2023. However, the company faced challenges with total expenditure, which decreased from 105.44 Cr in March 2022 to 77.62 Cr in March 2025. Operating profit, which was negative in March 2023 at -26.42 Cr, turned positive to 4.94 Cr in March 2025. Despite this improvement, the profit after tax remained negative at 3.01 Cr in March 2025, although it was an improvement from -27.74 Cr in March 2023. The consolidated net profit also showed a negative trend, reaching -9.97 Cr in March 2025, but this was less severe than the -20.90 Cr recorded in March 2023. The company's total liabilities decreased significantly from 194.56 Cr in March 2022 to 90.45 Cr in March 2024, reflecting a reduction in debt levels. Cash flow from operating activities remained negative, indicating ongoing challenges in generating cash from core operations. Overall, while Brooks Lab has shown signs of recovery in sales and operating profit, it continues to face challenges in profitability and cash flow management.